Megumi Yamamoto Selected Research

Megumi Yamamoto Research Topics

Disease

5	Neoplasms (Cancer) 08/2012 - 12/2003
4	Body Weight (Weight, Body) 01/2021 - 01/2005
3	Inflammation (Inflammations) 02/2020 - 03/2008
3	Alcoholism (Alcohol Abuse) 08/2004 - 01/2002
2	Obesity 01/2021 - 03/2014
2	Asthma (Bronchial Asthma) 10/2018 - 01/2016
2	Hypersensitivity (Allergy) 06/2018 - 05/2015
2	Stomach Neoplasms (Stomach Cancer) 05/2008 - 02/2008
2	Hepatocellular Carcinoma (Hepatoma) 01/2005 - 01/2004
2	Carcinogenesis 01/2005 - 01/2004
1	Infections 10/2022
1	Uterine Cervical Dysplasia 10/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022
1	Endometriosis 03/2021
1	Choroidal Neovascularization 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Insulin Resistance 01/2021
1	Weight Gain 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 12/2020
1	Ataxia (Dyssynergia) 04/2020
1	Optic Nerve Diseases (Optic Neuropathy) 01/2020
1	Optic Atrophy 01/2020
1	Diabetes Mellitus 04/2019
1	Hereditary Corneal Dystrophies 04/2019
1	Wounds and Injuries (Trauma) 04/2019
1	Bone Fractures (Bone Fracture) 01/2019
1	Osteoporosis 01/2019
1	Heart Failure 10/2018
1	Premature Birth (Birth, Premature) 10/2018
1	Nervous System Mercury Poisoning (Minamata Disease) 08/2018
1	Epstein-Barr Virus Infections 07/2017
1	Allergic Rhinitis 01/2016
1	Astrocytoma (Pilocytic Astrocytoma) 08/2015
1	Type 2 Diabetes Mellitus (MODY) 08/2014
1	Neuroblastoma 05/2014
1	Breast Neoplasms (Breast Cancer) 04/2010
1	Leukemia 03/2008

Drug/Important Bio-Agent (IBA)

4	Interleukin-6 (Interleukin 6)IBA 04/2020 - 08/2015
4	MercuryIBA 10/2018 - 01/2004
4	Messenger RNA (mRNA)IBA 07/2017 - 08/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2015
3	Acetylcysteine (Siran)FDA LinkGeneric 04/2020 - 08/2015
2	AdiponectinIBA 01/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
2	CadmiumIBA 10/2018 - 01/2004
2	SeleniumIBA 10/2018 - 05/2008
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 01/2016
2	Polychlorinated Biphenyls (PCBs)IBA 05/2015 - 04/2010
2	ArsenicIBA 03/2008 - 01/2004
2	Ethanol (Ethyl Alcohol)IBA 08/2004 - 02/2004
2	CalciumIBA 02/2004 - 01/2004
2	Biological ProductsIBA 02/2004 - 01/2002
1	VaccinesIBA 10/2022
1	Pioglitazone (Actos)FDA Link 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020
1	AntioxidantsIBA 02/2020
1	Chelating AgentsIBA 02/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Acyl Carrier ProteinIBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	Malonyl Coenzyme A (Malonyl CoA)IBA 01/2020
1	Parathyroid Hormone (Parathormone)IBA 01/2019
1	AntibodiesIBA 01/2019
1	LigandsIBA 01/2019
1	Diphosphonates (Bisphosphonates)IBA 01/2019
1	ManganeseIBA 10/2018
1	Heavy MetalsIBA 10/2018
1	trimellitic anhydrideIBA 06/2018
1	Immunoglobulin G (IgG)IBA 06/2018
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 06/2018
1	PlasticsIBA 06/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2017
1	Monocyte Chemoattractant ProteinsIBA 08/2015
1	InterleukinsIBA 08/2015
1	Environmental Pollutants (Pollutants, Environmental)IBA 05/2015
1	Air Pollutants (Pollutants, Air)IBA 05/2015
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 05/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2014
1	LipidsIBA 03/2014
1	Drug CarriersIBA 08/2012
1	Thyroid HormonesIBA 04/2010
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2010
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 04/2010
1	hydroxide ionIBA 04/2010
1	arseniteIBA 03/2008
1	NF-kappa B (NF-kB)IBA 03/2008
1	ZincIBA 02/2008
1	(2E,4E,6E,10E)- 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 01/2005
1	Transforming Growth Factor alpha (TGF-alpha)IBA 01/2005
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2005

Therapy/Procedure

1	Therapeutics 10/2022
1	Hysterectomy 03/2021
1	Lymph Node Excision (Lymph Node Dissection) 12/2020
1	Minimally Invasive Surgical Procedures 12/2020
1	Contact Lenses 04/2019
1	Activities of Daily Living (ADL) 01/2019